Myocardial uptake characteristics of three99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection

Annals of Nuclear Medicine

Volumn 20, Issue 10, 2006, Pages 663-670

  Manka Waluch, Agnieszka ^a   Palmedo, Holger ^a   Reinhardt, Michael J ^a   Joe, Alexius Y ^a   Manka, Christoph ^a   Guhlke, Stefan ^a   Biersack, Hans Jürgen ^a   Bucerius, Jan ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

99mTc cardiospect MIBI; 99mTc sestamibi; 99mTc tetrofosmin; Myocardial uptake; Pulmonary uptake

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIO SPECT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; TECHNETIUM 99M; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE PERFUSION; HUMAN; IMAGING; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CORONARY ARTERIOSCLEROSIS; FEMALE; HEART; HUMANS; INJECTIONS, INTRA-ARTERIAL; LUNG; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REST; TECHNETIUM TC 99M SESTAMIBI; TISSUE DISTRIBUTION; VENTRICULAR DYSFUNCTION, LEFT; WHOLE BODY IMAGING;

EID: 33846467703     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984677     Document Type: Article

References (16)

1. Hurwitz GA, Ghali SK, Husni M, et al. Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole-based stress or exercise. J Nucl Med 1998; 39: 339-345.
2. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993; 72: 1015-1019.
3. Acampa W, Cuocolo A, Sullo P, et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 1998; 3: 265-274.
4. Münch G, Neverve J, Matsunari I, Schröter G, Schwaiger M. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med 1997; 38: 428-432.
5. Soman P, Taillefer R, DePuey EG, Undelson JE, Lahiri A. Enhanced detection of reversible perfusion defects by Tc-99m-sestamibi during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. J Am Coll Cardiol 2001; 37: 458-462.
6. Kapur A, Latus KA, Davies G, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med 2002; 29: 1608-1616.
7. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m- Tetrofosmin, Technetium-99m-MIBI and Thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39: 266-271.
8. Flamen P, Bossuyt A, Franken PR. Technetium-99m-Tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 1995; 36: 2009-2015.
9. Iskander S, Iskander AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998; 32: 57-62.
10. Schuijf JD, Shaw LJ, Wijns W, et al. Cardiac imaging in coronary artery disease: differing modalities. Heart 2005; 91: 1110-1117.
11. Caner B, Beller GA. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability? Clin Cardiol 1998; 21: 235-242.
12. Bangard M, Bender H, Grünwald F, et al. Myocardial uptake of Technetium-99m-Furifosmin (Q12) versus Technetium-99m-Sestamibi (MIBI). Nuklearmedizin 1999; 38: 189-191.
13. Jain D. Technetium99m labelled myocardial perfusion imaging agents. Semin Nucl Med 1999; 29: 221-236.
14. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-ethoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
15. Jain D, Zaret BL. Technetium 99m Tetrofosmin. In: Iskandrian AE, Verani MS, eds. New developments in cardiac nuclear imaging. Armonk, NY; Futura Publishing, 1998: 29-58.
16. Maisey MN, Mistry R, Sowton E. Planar imaging techniques used with technetium-99m-sestamibi kinetics to evaluate chronic myocardial ischemia. Am J Cardiol 1990; 66: 47E-54E.